01 1DARMERICA, LLC
02 1Nanjing XiShengNuo Biological Technology Co., Ltd.
03 1Qingdao Biopeptek Co., Ltd.
01 1AOD 9604 Acetate
02 1AOD9604 Acetate
03 1AOD9604 acetate
01 2U.S.A
02 1Blank
NDC Package Code : 73212-001
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-633
Start Marketing Date : 2019-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 83726-120
Start Marketing Date : 2023-10-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A AOD 9604 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AOD 9604, including repackagers and relabelers. The FDA regulates AOD 9604 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AOD 9604 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AOD 9604 supplier is an individual or a company that provides AOD 9604 active pharmaceutical ingredient (API) or AOD 9604 finished formulations upon request. The AOD 9604 suppliers may include AOD 9604 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AOD 9604 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AOD 9604 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AOD 9604 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AOD 9604 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AOD 9604 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AOD 9604 suppliers with NDC on PharmaCompass.
We have 2 companies offering AOD 9604
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
